{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:29:04Z","timestamp":1790753344420,"version":"4.1.0"},"reference-count":110,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.molmed.2020.11.008","type":"journal-article","created":{"date-parts":[[2020,12,17]],"date-time":"2020-12-17T07:31:34Z","timestamp":1608190294000},"page":"394-409","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["A Rare Kidney Disease To Cure Them All? Towards Mechanism-Based Therapies for Proteinopathies"],"prefix":"10.1016","volume":"27","author":[{"given":"Moran","family":"Dvela-Levitt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jillian L.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5697-7791","authenticated-orcid":false,"given":"Anna","family":"Greka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2020.11.008_bb0005","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nrneph.2015.152","article-title":"Nephrology research \u2013 the past, present and future","volume":"11","author":"Floege","year":"2015","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.molmed.2020.11.008_bb0010","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/MNH.0000000000000270","article-title":"Multimorbidity in people with chronic kidney disease: implications for outcomes and treatment","volume":"25","author":"Fraser","year":"2016","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.molmed.2020.11.008_bb0015","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ekir.2017.04.001","article-title":"Exploring novel endpoints for clinical trials in kidney disease: challenges and opportunities","volume":"2","author":"Roy-Chaudhury","year":"2017","journal-title":"Kidney Int. Rep."},{"key":"10.1016\/j.molmed.2020.11.008_bb0020","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.2215\/CJN.03660320","article-title":"Advancing American Kidney Health (AAKH): catalyst for investment in kidney diseases clinical trials and precision medicine: an opportunity to advance upstream interventions and the importance of nephrology","volume":"15","author":"Fowler","year":"2020","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.molmed.2020.11.008_bb0025","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1056\/NEJMoa1806891","article-title":"Diagnostic utility of exome sequencing for kidney disease. Reply","volume":"380","author":"Groopman","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2020.11.008_bb0030","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41572-019-0109-9","article-title":"Autosomal dominant tubulointerstitial kidney disease","volume":"5","author":"Devuyst","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.molmed.2020.11.008_bb0035","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.88","article-title":"Chronic kidney disease","volume":"3","author":"Romagnani","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.molmed.2020.11.008_bb0040","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.kint.2020.02.010","article-title":"Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) consensus conference","volume":"97","author":"Levey","year":"2020","journal-title":"Kidney Int."},{"key":"10.1016\/j.molmed.2020.11.008_bb0045","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/ki.2015.230","article-title":"A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010","volume":"88","author":"Mills","year":"2015","journal-title":"Kidney Int."},{"key":"10.1016\/j.molmed.2020.11.008_bb0050","series-title":"Chronic Kidney Disease in the United States, 2019","author":"Centers for Disease Control and Prevention","year":"2019"},{"key":"10.1016\/j.molmed.2020.11.008_bb0055","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/nep.13464","article-title":"Chronic kidney disease epidemic: how do we deal with it?","volume":"23","author":"Ng","year":"2018","journal-title":"Nephrology"},{"key":"10.1016\/j.molmed.2020.11.008_bb0060","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/317542a0","article-title":"A highly polymorphic DNA marker linked to adult polycystic kidney disease on chromosome 16","volume":"317","author":"Reeders","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2020.11.008_bb0065","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1016\/S0140-6736(14)60659-0","article-title":"Rare inherited kidney diseases: challenges, opportunities, and perspectives","volume":"383","author":"Devuyst","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.molmed.2020.11.008_bb0070","doi-asserted-by":"crossref","first-page":"c194","DOI":"10.1159\/000339785","article-title":"Orphan kidney diseases","volume":"120","author":"Soliman","year":"2012","journal-title":"Nephron. Clin. Pract."},{"key":"10.1016\/j.molmed.2020.11.008_bb0075","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3004980","article-title":"The battlefield of rare diseases: where uncommon insights are common","volume":"4","author":"Gahl","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.molmed.2020.11.008_bb0080","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1126\/science.3513311","article-title":"A receptor-mediated pathway for cholesterol homeostasis","volume":"232","author":"Brown","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.molmed.2020.11.008_bb0085","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1073\/pnas.71.3.788","article-title":"Familial hypercholesterolemia: defective binding of lipoproteins to cultured fibroblasts associated with impaired regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity","volume":"71","author":"Brown","year":"1974","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2020.11.008_bb0090","doi-asserted-by":"crossref","first-page":"14833","DOI":"10.1073\/pnas.1312967110","article-title":"Discovery of the cellular and molecular basis of cholesterol control","volume":"110","author":"Schekman","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2020.11.008_bb0095","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.cell.2015.01.036","article-title":"A century of cholesterol and coronaries: from plaques to genes to statins","volume":"161","author":"Goldstein","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2020.11.008_bb0100","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1126\/science.7112129","article-title":"Cystine transport is defective in isolated leukocyte lysosomes from patients with cystinosis","volume":"217","author":"Gahl","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.molmed.2020.11.008_bb0105","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1056\/NEJM199304223281604","article-title":"Improved renal function in children with cystinosis treated with cysteamine","volume":"328","author":"Markello","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2020.11.008_bb0110","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.3389\/fneur.2019.01315","article-title":"Therapeutic applications of cysteamine and cystamine in neurodegenerative and neuropsychiatric diseases","volume":"10","author":"Paul","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.molmed.2020.11.008_bb0115","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.ajpath.2011.12.023","article-title":"The Gne M712T mouse as a model for human glomerulopathy","volume":"180","author":"Kakani","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.molmed.2020.11.008_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029873","article-title":"Glycoprotein hyposialylation gives rise to a nephrotic-like syndrome that is prevented by sialic acid administration in GNE V572L point-mutant mice","volume":"7","author":"Ito","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.molmed.2020.11.008_bb0125","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1172\/JCI30954","article-title":"Mutation in the key enzyme of sialic acid biosynthesis causes severe glomerular proteinuria and is rescued by N-acetylmannosamine","volume":"117","author":"Galeano","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2020.11.008_bb0130","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.ekir.2019.06.012","article-title":"Rationale and design for a Phase 1 study of N-acetylmannosamine for primary glomerular diseases","volume":"4","author":"Huizing","year":"2019","journal-title":"Kidney Int. Rep."},{"key":"10.1016\/j.molmed.2020.11.008_bb0135","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.semnephrol.2010.06.003","article-title":"Hereditary interstitial kidney disease","volume":"30","author":"Bleyer","year":"2010","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.molmed.2020.11.008_bb0140","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/ng.2543","article-title":"Mutations causing medullary cystic kidney disease type 1 lie in a large VNTR in MUC1 missed by massively parallel sequencing","volume":"45","author":"Kirby","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2020.11.008_bb0145","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cell.2019.07.002","article-title":"Small molecule targets TMED9 and promotes lysosomal degradation to reverse proteinopathy","volume":"178","author":"Dvela-Levitt","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2020.11.008_bb0150","doi-asserted-by":"crossref","first-page":"30093","DOI":"10.1074\/jbc.270.50.30093","article-title":"Delayed mammary tumor progression in Muc-1 null mice","volume":"270","author":"Spicer","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2020.11.008_bb0155","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1681\/ASN.2018020180","article-title":"Noninvasive immunohistochemical diagnosis and novel MUC1 mutations causing autosomal dominant tubulointerstitial kidney disease","volume":"29","author":"Zivna","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.molmed.2020.11.008_bb0160","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nrneph.2017.101","article-title":"Uromodulin: from physiology to rare and complex kidney disorders","volume":"13","author":"Devuyst","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.molmed.2020.11.008_bb0165","doi-asserted-by":"crossref","first-page":"7383","DOI":"10.1038\/s41598-017-07804-6","article-title":"Early involvement of cellular stress and inflammatory signals in the pathogenesis of tubulointerstitial kidney disease due to UMOD mutations","volume":"7","author":"Trudu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molmed.2020.11.008_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0175970","article-title":"Mutant uromodulin expression leads to altered homeostasis of the endoplasmic reticulum and activates the unfolded protein response","volume":"12","author":"Schaeffer","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.molmed.2020.11.008_bb0175","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/s41588-019-0407-x","article-title":"A catalog of genetic loci associated with kidney function from analyses of a million individuals","volume":"51","author":"Wuttke","year":"2019","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2020.11.008_bb0180","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s00467-018-4031-2","article-title":"Endoplasmic reticulum stress and monogenic kidney diseases in precision nephrology","volume":"34","author":"Park","year":"2019","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.molmed.2020.11.008_bb0185","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.92896","article-title":"Elevated urinary CRELD2 is associated with endoplasmic reticulum stress-mediated kidney disease","volume":"2","author":"Kim","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.molmed.2020.11.008_bb0190","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1126\/science.aaz9866","article-title":"Architecture and function of human uromodulin filaments in urinary tract infections","volume":"369","author":"Weiss","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.molmed.2020.11.008_bb0195","doi-asserted-by":"crossref","first-page":"5462","DOI":"10.1038\/s41467-019-13382-0","article-title":"Single cell census of human kidney organoids shows reproducibility and diminished off-target cells after transplantation","volume":"10","author":"Subramanian","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2020.11.008_bb0200","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nprot.2016.170","article-title":"Generation of nephron progenitor cells and kidney organoids from human pluripotent stem cells","volume":"12","author":"Morizane","year":"2017","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.molmed.2020.11.008_bb0205","doi-asserted-by":"crossref","DOI":"10.1038\/srep38353","article-title":"Generation of kidney tubular organoids from human pluripotent stem cells","volume":"6","author":"Yamaguchi","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molmed.2020.11.008_bb0210","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1038\/nprot.2016.098","article-title":"Generation of kidney organoids from human pluripotent stem cells","volume":"11","author":"Takasato","year":"2016","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.molmed.2020.11.008_bb0215","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.cell.2016.05.082","article-title":"Modeling development and disease with organoids","volume":"165","author":"Clevers","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2020.11.008_bb0220","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/j.ekir.2020.06.029","article-title":"Genetic and clinical predictors of age of ESKD in individuals with autosomal dominant tubulointerstitial kidney disease due to UMOD mutations","volume":"5","author":"Kidd","year":"2020","journal-title":"Kidney Int. Rep."},{"key":"10.1016\/j.molmed.2020.11.008_bb0225","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.kint.2020.04.038","article-title":"Clinical and genetic spectra of autosomal dominant tubulointerstitial kidney disease due to mutations in UMOD and MUC1","volume":"98","author":"Olinger","year":"2020","journal-title":"Kidney Int."},{"key":"10.1016\/j.molmed.2020.11.008_bb0230","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41573-019-0049-9","article-title":"Therapies for rare diseases: therapeutic modalities, progress and challenges ahead","volume":"19","author":"Tambuyzer","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.molmed.2020.11.008_bb0235","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nm.4306","article-title":"The Drug Repurposing Hub: a next-generation drug library and information resource","volume":"23","author":"Corsello","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2020.11.008_bb0240","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1203\/00006450-199102000-00009","article-title":"Phenylacetylglutamine may replace urea as a vehicle for waste nitrogen excretion","volume":"29","author":"Brusilow","year":"1991","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.molmed.2020.11.008_bb0245","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1385\/JMN:23:1-2:041","article-title":"CFTR and chaperones: processing and degradation","volume":"23","author":"Amaral","year":"2004","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.molmed.2020.11.008_bb0250","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1172\/JCI119788","article-title":"In vitro pharmacologic restoration of CFTR-mediated chloride transport with sodium 4-phenylbutyrate in cystic fibrosis epithelial cells containing delta F508-CFTR","volume":"100","author":"Rubenstein","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2020.11.008_bb0255","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.26624","article-title":"ER retention is imposed by COPII protein sorting and attenuated by 4-phenylbutyrate","volume":"6","author":"Ma","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.molmed.2020.11.008_bb0260","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1167\/iovs.11-8837","article-title":"Topical ocular sodium 4-phenylbutyrate rescues glaucoma in a myocilin mouse model of primary open-angle glaucoma","volume":"53","author":"Zode","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.molmed.2020.11.008_bb0265","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1097\/01.ASN.0000129826.28932.FD","article-title":"Defective trafficking of nephrin missense mutants rescued by a chemical chaperone","volume":"15","author":"Liu","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.molmed.2020.11.008_bb0270","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0092-8674(95)90240-6","article-title":"Degradation of CFTR by the ubiquitin-proteasome pathway","volume":"83","author":"Ward","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2020.11.008_bb0275","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/363263a0","article-title":"CFTR and outward rectifying chloride channels are distinct proteins with a regulatory relationship","volume":"363","author":"Gabriel","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2020.11.008_bb0280","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1126\/science.7543698","article-title":"CFTR as a cAMP-dependent regulator of sodium channels","volume":"269","author":"Stutts","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.molmed.2020.11.008_bb0285","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1091\/mbc.12.4.957","article-title":"Deletion of yeast p24 genes activates the unfolded protein response","volume":"12","author":"Belden","year":"2001","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.molmed.2020.11.008_bb0290","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1083\/jcb.200710025","article-title":"The yeast p24 complex is required for the formation of COPI retrograde transport vesicles from the Golgi apparatus","volume":"180","author":"Aguilera-Romero","year":"2008","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.molmed.2020.11.008_bb0295","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/1471-2164-9-212","article-title":"Loss of p24 function in Drosophila melanogaster causes a stress response and increased levels of NF-kappaB-regulated gene products","volume":"9","author":"Boltz","year":"2008","journal-title":"BMC Genomics"},{"key":"10.1016\/j.molmed.2020.11.008_bb0300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182995","article-title":"Non-alcoholic fatty liver disease in mice with heterozygous mutation in TMED2","volume":"12","author":"Hou","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.molmed.2020.11.008_bb0305","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3389\/fncel.2019.00328","article-title":"TMP21 in Alzheimer's disease: molecular mechanisms and a potential target","volume":"13","author":"Qiu","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.molmed.2020.11.008_bb0310","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.nbd.2008.06.012","article-title":"Localization and regional distribution of p23\/TMP21 in the brain","volume":"32","author":"Vetrivel","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.molmed.2020.11.008_bb0315","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/nature04667","article-title":"TMP21 is a presenilin complex component that modulates gamma-secretase but not epsilon-secretase activity","volume":"440","author":"Chen","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2020.11.008_bb0320","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.cell.2020.03.031","article-title":"A translocation pathway for vesicle-mediated unconventional protein secretion","volume":"181","author":"Zhang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2020.11.008_bb0325","doi-asserted-by":"crossref","first-page":"18414","DOI":"10.1074\/jbc.M110.209718","volume":"286","author":"Jimenez","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2020.11.008_bb0330","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1042\/BJ20070234","article-title":"Mammalian GPI-anchored proteins require p24 proteins for their efficient transport from the ER to the plasma membrane","volume":"409","author":"Takida","year":"2008","journal-title":"Biochem. J."},{"key":"10.1016\/j.molmed.2020.11.008_bb0335","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.cell.2014.06.026","article-title":"ER stress-induced clearance of misfolded GPI-anchored proteins via the secretory pathway","volume":"158","author":"Satpute-Krishnan","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2020.11.008_bb0340","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.46740","article-title":"Misfolded GPI-anchored proteins are escorted through the secretory pathway by ER-derived factors","volume":"8","author":"Zavodszky","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.molmed.2020.11.008_bb0345","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1016\/j.celrep.2018.05.017","article-title":"Cytomegalovirus gp40\/m152 uses TMED10 as ER anchor to retain MHC class I","volume":"23","author":"Ramnarayan","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.molmed.2020.11.008_bb0350","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1016\/j.celrep.2018.11.048","article-title":"TMED2 potentiates cellular IFN responses to DNA viruses by reinforcing MITA dimerization and facilitating its trafficking","volume":"25","author":"Sun","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.molmed.2020.11.008_bb0355","doi-asserted-by":"crossref","first-page":"882","DOI":"10.15252\/emmm.201303799","article-title":"A novel genome-wide in vivo screen for metastatic suppressors in human colon cancer identifies the positive WNT\u2013TCF pathway modulators TMED3 and SOX12","volume":"6","author":"Duquet","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.molmed.2020.11.008_bb0360","doi-asserted-by":"crossref","first-page":"5817","DOI":"10.1038\/s41388-019-0845-z","article-title":"The protein secretion modulator TMED9 drives CNIH4\/TGFalpha\/GLI signaling opposing TMED3\u2013WNT\u2013TCF to promote colon cancer metastases","volume":"38","author":"Mishra","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.molmed.2020.11.008_bb0365","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1042\/BC20080233","article-title":"The p24 family and selective transport processes at the ER\u2013Golgi interface","volume":"101","author":"Strating","year":"2009","journal-title":"Biol. Cell."},{"key":"10.1016\/j.molmed.2020.11.008_bb0370","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ceb.2020.04.002","article-title":"Protein quality control in the endoplasmic reticulum","volume":"65","author":"Phillips","year":"2020","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.molmed.2020.11.008_bb0375","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/74166","article-title":"NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome","volume":"24","author":"Boute","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2020.11.008_bb0380","doi-asserted-by":"crossref","first-page":"e907","DOI":"10.1542\/peds.2006-2164","article-title":"Nephrotic syndrome in the first year of life: two thirds of cases are caused by mutations in 4 genes (NPHS1, NPHS2, WT1, and LAMB2)","volume":"119","author":"Hinkes","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.molmed.2020.11.008_bb0385","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1681\/ASN.2012121149","article-title":"Laminin beta2 gene missense mutation produces endoplasmic reticulum stress in podocytes","volume":"24","author":"Chen","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.molmed.2020.11.008_bb0390","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/73456","article-title":"Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis","volume":"24","author":"Kaplan","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2020.11.008_bb0395","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1172\/JCI78863","article-title":"Sec63 and Xbp1 regulate IRE1alpha activity and polycystic disease severity","volume":"125","author":"Fedeles","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2020.11.008_bb0400","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.molmed.2006.10.004","article-title":"Protein transport into the endoplasmic reticulum: mechanisms and pathologies","volume":"12","author":"Zimmermann","year":"2006","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.molmed.2020.11.008_bb0405","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.ajhg.2018.03.013","article-title":"Monoallelic mutations to DNAJB11 cause atypical autosomal-dominant polycystic kidney disease","volume":"102","author":"Cornec-Le Gall","year":"2018","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.molmed.2020.11.008_bb0410","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1172\/JCI64313","article-title":"Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity","volume":"122","author":"Hopp","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2020.11.008_bb0415","first-page":"185","article-title":"Establishing patient registries for rare diseases: rationale and challenges","volume":"34","author":"Boulanger","year":"2020","journal-title":"Pharmaceut. Med."},{"key":"10.1016\/j.molmed.2020.11.008_bb0420","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13023-018-0810-x","article-title":"Patient reported outcome measures in rare diseases: a narrative review","volume":"13","author":"Slade","year":"2018","journal-title":"Orphanet. J. Rare Dis."},{"key":"10.1016\/j.molmed.2020.11.008_bb0425","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1093\/hmg\/11.26.3333","article-title":"Prevention of pathology in mdx mice by expression of utrophin: analysis using an inducible transgenic expression system","volume":"11","author":"Squire","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2020.11.008_bb0430","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1093\/ndt\/gfz028","article-title":"Personalized medicine in chronic kidney disease by detection of monogenic mutations","volume":"35","author":"Connaughton","year":"2020","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.molmed.2020.11.008_bb0435","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ajhg.2009.07.010","article-title":"Dominant renin gene mutations associated with early-onset hyperuricemia, anemia, and chronic kidney failure","volume":"85","author":"Zivna","year":"2009","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.molmed.2020.11.008_bb0440","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.kint.2020.06.041","article-title":"An international cohort study of autosomal dominant tubulointerstitial kidney disease due to REN mutations identifies distinct clinical subtypes","volume":"98","author":"Zivna","year":"2020","journal-title":"Kidney Int."},{"key":"10.1016\/j.molmed.2020.11.008_bb0445","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1093\/hmg\/8.11.2001","article-title":"A novel syndrome of diabetes mellitus, renal dysfunction and genital malformation associated with a partial deletion of the pseudo-POU domain of hepatocyte nuclear factor-1beta","volume":"8","author":"Lindner","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2020.11.008_bb0450","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ajhg.2016.05.028","article-title":"Heterozygous loss-of-function SEC61A1 mutations cause autosomal-dominant tubulo-interstitial and glomerulocystic kidney disease with anemia","volume":"99","author":"Bolar","year":"2016","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.molmed.2020.11.008_bb0455","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.cub.2015.03.029","article-title":"Traffic of p24 proteins and COPII coat composition mutually influence membrane scaffolding","volume":"25","author":"D'Arcangelo","year":"2015","journal-title":"Curr. Biol."},{"key":"10.1016\/j.molmed.2020.11.008_bb0460","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s00709-015-0858-6","article-title":"p24 family proteins: key players in the regulation of trafficking along the secretory pathway","volume":"253","author":"Pastor-Cantizano","year":"2016","journal-title":"Protoplasma"},{"key":"10.1016\/j.molmed.2020.11.008_bb0465","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1002\/j.1460-2075.1995.tb07119.x","article-title":"The absence of Emp24p, a component of ER-derived COPII-coated vesicles, causes a defect in transport of selected proteins to the Golgi","volume":"14","author":"Schimmoller","year":"1995","journal-title":"EMBO J."},{"key":"10.1016\/j.molmed.2020.11.008_bb0470","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1083\/jcb.131.4.895","article-title":"The Golgi-localization of yeast Emp47p depends on its di-lysine motif but is not affected by the ret1-1 mutation in alpha-COP","volume":"131","author":"Schroder","year":"1995","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.molmed.2020.11.008_bb0475","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ydbio.2010.02.019","article-title":"The trafficking protein Tmed2\/p24beta1 is required for morphogenesis of the mouse embryo and placenta","volume":"341","author":"Jerome-Majewska","year":"2010","journal-title":"Dev. Biol."},{"key":"10.1016\/j.molmed.2020.11.008_bb0480","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.celrep.2018.12.041","article-title":"Proteomic profiling of mammalian COPII and COPI vesicles","volume":"26","author":"Adolf","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.molmed.2020.11.008_bb0485","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.molmed.2019.08.011","article-title":"Chemical strike against a dominant-inherited MUC1-frameshifted protein associated with progressive kidney disease","volume":"25","author":"Thomas","year":"2019","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.molmed.2020.11.008_bb0490","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1083\/jcb.201610031","article-title":"Protein sorting at the ER\u2013Golgi interface","volume":"215","author":"Gomez-Navarro","year":"2016","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.molmed.2020.11.008_bb0495","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1369\/jhc.6A7093.2006","article-title":"A subset of p23 localized on secretory granules in pancreatic beta-cells","volume":"55","author":"Hosaka","year":"2007","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.molmed.2020.11.008_bb0500","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1016\/j.febslet.2010.03.041","article-title":"p24 family type 1 transmembrane proteins are required for insulin biosynthesis and secretion in pancreatic beta-cells","volume":"584","author":"Zhang","year":"2010","journal-title":"FEBS Lett."},{"key":"10.1016\/j.molmed.2020.11.008_bb0505","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1242\/jcs.113.13.2507","article-title":"Coupled transport of p24 family members","volume":"113","author":"Emery","year":"2000","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.molmed.2020.11.008_bb0510","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1242\/jcs.112.4.537","article-title":"Intracellular localization and in vivo trafficking of p24A and p23","volume":"112","author":"Blum","year":"1999","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.molmed.2020.11.008_bb0515","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.biocel.2009.02.010","article-title":"COP-binding sites in p24delta2 are necessary for proper secretory cargo biosynthesis","volume":"41","author":"Strating","year":"2009","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.molmed.2020.11.008_bb0520","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0014-5793(99)00246-X","article-title":"p24 and p23, the major transmembrane proteins of COPI-coated transport vesicles, form hetero-oligomeric complexes and cycle between the organelles of the early secretory pathway","volume":"447","author":"Gommel","year":"1999","journal-title":"FEBS Lett."},{"key":"10.1016\/j.molmed.2020.11.008_bb0525","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1083\/jcb.146.2.285","article-title":"Roles for alpha2p24 and COPI in endoplasmic reticulum cargo exit site formation","volume":"146","author":"Lavoie","year":"1999","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.molmed.2020.11.008_bb0530","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1083\/jcb.139.5.1119","article-title":"Involvement of the transmembrane protein p23 in biosynthetic protein transport","volume":"139","author":"Rojo","year":"1997","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.molmed.2020.11.008_bb0535","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1091\/mbc.e07-10-0989","article-title":"The cargo receptors Surf4, endoplasmic reticulum\u2013Golgi intermediate compartment (ERGIC)-53, and p25 are required to maintain the architecture of ERGIC and Golgi","volume":"19","author":"Mitrovic","year":"2008","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.molmed.2020.11.008_bb0540","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40035-017-0077-5","article-title":"Protein misfolding in neurodegenerative diseases: implications and strategies","volume":"6","author":"Sweeney","year":"2017","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.molmed.2020.11.008_bb0545","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3389\/fnins.2017.00048","article-title":"The emerging roles of early protein folding events in the secretory pathway in the development of neurodegenerative maladies","volume":"11","author":"Dubnikov","year":"2017","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.molmed.2020.11.008_bb0550","doi-asserted-by":"crossref","first-page":"a028035","DOI":"10.1101\/cshperspect.a028035","article-title":"Pathology of neurodegenerative diseases","volume":"9","author":"Dugger","year":"2017","journal-title":"Cold Spring Harb. Perspect. Biol."}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491420303129?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491420303129?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T07:21:54Z","timestamp":1761463314000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491420303129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":110,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S1471491420303129"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2020.11.008","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Rare Kidney Disease To Cure Them All? Towards Mechanism-Based Therapies for Proteinopathies","name":"articletitle","label":"Article Title"},{"value":"Trends in Molecular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmed.2020.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}